NI vs TELO · P/E 23, rev $3.61B vs $86.0M cap
NiSource Inc (NI) versus Telomir Pharmaceuticals, Inc. Common Stock (TELO) — a side-by-side from cached financials, not a winner call.
NiSource Inc (NI) is a utilities - regulated gas company listed on NYSE.
Telomir Pharmaceuticals, Inc. Common Stock (TELO) is a biotechnology company listed on NASDAQ.
Latest reported NI revenue for 2026-06-30 was $3.61B. Net income was $552.6M. Revenue was up 55.5% from 2026-03-31 to 2026-06-30. NI currently screens at market cap $22.42B and trailing P/E 23.3.
TELO does not have a complete income-statement cache yet.
NI currently screens at market cap $22.42B and trailing P/E 23.3. TELO currently screens at market cap $86.0M.
Not investment advice. Open the NI and TELO stock pages for the full models.
Not investment advice.